Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 195

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 195
---
1,633,781 | ) |
| Net increase/(decrease) in cash and cash equivalents                                     |     |              |    358,671 |   |     |        |     45,510 |   |     |        |    (17,332 | ) |
| Effect of foreign currency translation on cash and cash equivalents                      |     |              |     44,965 |   |     |        |    (18,962 | ) |     |        |     16,124 |   |
| Cash and cash equivalents, beginning of year                                             |     |              |     54,104 |   |     |        |     27,556 |   |     |        |     28,764 |   |
| Cash and cash equivalents, end of year                                                   |     | $            |    457,740 |   |     | $      |     54,104 |   |     |        |     27,556 |   |
| Supplementary cash flow information:                                                     |     |              |            |   |     |        |            |   |     |        |            |   |
| Taxes paid                                                                               |     | $            |          — |   |     | $      |          — |   |     |        |    (12,170 | ) |
| Interest paid                                                                            |     | $            |   (768,068 | ) |     | $      |    (24,704 | ) |     |        |    (55,469 | ) |

| ** | Re-presented as mentioned in Note 23 |

During the year ended December 31, 2024, no cash was exchanged in respect
of these transactions:

| a. | $2,650,000 of convertible debt was converted into equity. |

| b. | Reversal arising from remeasurement of share-based compensation within prepayment amounting to $2,739,856. |

<div align='center'>The accompanying notes are an integral part of
these consolidated financial statements.

F-8

NEWGENIVF GROUP LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2024, 2023 AND 2022
(Stated in US Dollars)</div>

NOTE 1 — ORGANIZATION AND PRINCIPAL ACTIVITIES

Prior to the Business Combination,
on April 29, 2021, A SPAC I Acquisition Corp